Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease

M. Rodinova, J. Krizova, H. Stufkova, B. Bohuslavova, G. Askeland, Z. Dosoudilova, S. Juhas, J. Juhasova, Z. Ellederova, J. Zeman, L. Eide, J. Motlik, H. Hansikova,

. 2019 ; 12 (7) : . [pub] 20190726

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Skeletal muscle wasting and atrophy is one of the more severe clinical impairments resulting from the progression of Huntington's disease (HD). Mitochondrial dysfunction may play a significant role in the etiology of HD, but the specific condition of mitochondria in muscle has not been widely studied during the development of HD. To determine the role of mitochondria in skeletal muscle during the early stages of HD, we analyzed quadriceps femoris muscle from 24-, 36-, 48- and 66-month-old transgenic minipigs that expressed the N-terminal portion of mutated human huntingtin protein (TgHD) and age-matched wild-type (WT) siblings. We found altered ultrastructure of TgHD muscle tissue and mitochondria. There was also significant reduction of activity of citrate synthase and respiratory chain complexes (RCCs) I, II and IV, decreased quantity of oligomycin-sensitivity conferring protein (OSCP) and the E2 subunit of pyruvate dehydrogenase (PDHE2), and differential expression of optic atrophy 1 protein (OPA1) and dynamin-related protein 1 (DRP1) in the skeletal muscle of TgHD minipigs. Statistical analysis identified several parameters that were dependent only on HD status and could therefore be used as potential biomarkers of disease progression. In particular, the reduction of biomarker RCCII subunit SDH30 quantity suggests that similar pathogenic mechanisms underlie disease progression in TgHD minipigs and HD patients. The perturbed biochemical phenotype was detectable in TgHD minipigs prior to the development of ultrastructural changes and locomotor impairment, which become evident at the age of 48 months. Mitochondrial disturbances may contribute to energetic depression in skeletal muscle in HD, which is in concordance with the mobility problems observed in this model.This article has an associated First Person interview with the first author of the paper.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023808
003      
CZ-PrNML
005      
20201214131257.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1242/dmm.038737 $2 doi
035    __
$a (PubMed)31278192
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Rodinova, Marie $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
245    10
$a Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease / $c M. Rodinova, J. Krizova, H. Stufkova, B. Bohuslavova, G. Askeland, Z. Dosoudilova, S. Juhas, J. Juhasova, Z. Ellederova, J. Zeman, L. Eide, J. Motlik, H. Hansikova,
520    9_
$a Skeletal muscle wasting and atrophy is one of the more severe clinical impairments resulting from the progression of Huntington's disease (HD). Mitochondrial dysfunction may play a significant role in the etiology of HD, but the specific condition of mitochondria in muscle has not been widely studied during the development of HD. To determine the role of mitochondria in skeletal muscle during the early stages of HD, we analyzed quadriceps femoris muscle from 24-, 36-, 48- and 66-month-old transgenic minipigs that expressed the N-terminal portion of mutated human huntingtin protein (TgHD) and age-matched wild-type (WT) siblings. We found altered ultrastructure of TgHD muscle tissue and mitochondria. There was also significant reduction of activity of citrate synthase and respiratory chain complexes (RCCs) I, II and IV, decreased quantity of oligomycin-sensitivity conferring protein (OSCP) and the E2 subunit of pyruvate dehydrogenase (PDHE2), and differential expression of optic atrophy 1 protein (OPA1) and dynamin-related protein 1 (DRP1) in the skeletal muscle of TgHD minipigs. Statistical analysis identified several parameters that were dependent only on HD status and could therefore be used as potential biomarkers of disease progression. In particular, the reduction of biomarker RCCII subunit SDH30 quantity suggests that similar pathogenic mechanisms underlie disease progression in TgHD minipigs and HD patients. The perturbed biochemical phenotype was detectable in TgHD minipigs prior to the development of ultrastructural changes and locomotor impairment, which become evident at the age of 48 months. Mitochondrial disturbances may contribute to energetic depression in skeletal muscle in HD, which is in concordance with the mobility problems observed in this model.This article has an associated First Person interview with the first author of the paper.
650    _2
$a zvířata $7 D000818
650    _2
$a geneticky modifikovaná zvířata $7 D030801
650    _2
$a tělesná hmotnost $7 D001835
650    _2
$a DNA $x metabolismus $7 D004247
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a progrese nemoci $7 D018450
650    _2
$a transport elektronů $7 D004579
650    12
$a energetický metabolismus $7 D004734
650    _2
$a lidé $7 D006801
650    _2
$a protein huntingtin $x genetika $7 D000071058
650    _2
$a Huntingtonova nemoc $x metabolismus $x patologie $7 D006816
650    _2
$a svalové mitochondrie $x metabolismus $x ultrastruktura $7 D008931
650    _2
$a mitochondriální proteiny $x metabolismus $7 D024101
650    _2
$a kosterní svaly $x metabolismus $x ultrastruktura $7 D018482
650    _2
$a mutace $7 D009154
650    _2
$a oxidativní fosforylace $7 D010085
650    _2
$a prasata $7 D013552
650    _2
$a miniaturní prasata $7 D013556
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Krizova, Jana $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
700    1_
$a Stufkova, Hana $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
700    1_
$a Bohuslavova, Bozena $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
700    1_
$a Askeland, Georgina $u Department of Medical Biochemistry, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway.
700    1_
$a Dosoudilova, Zaneta $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
700    1_
$a Juhas, Stefan $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
700    1_
$a Juhasova, Jana $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
700    1_
$a Ellederova, Zdenka $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
700    1_
$a Zeman, Jiri $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic.
700    1_
$a Eide, Lars $u Department of Medical Biochemistry, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway.
700    1_
$a Motlik, Jan $u Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics AS CR, 27721 Liběchov, Czech Republic.
700    1_
$a Hansikova, Hana $u Laboratory for Study of Mitochondrial Disorders, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12108 Prague 2, Czech Republic hana.hansikova@lf1.cuni.cz.
773    0_
$w MED00173721 $t Disease models & mechanisms $x 1754-8411 $g Roč. 12, č. 7 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31278192 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214131255 $b ABA008
999    __
$a ok $b bmc $g 1596127 $s 1114484
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 12 $c 7 $e 20190726 $i 1754-8411 $m Disease models & mechanisms $n Dis Model Mech $x MED00173721
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...